"This blog was developed to provide medical updates that are important and have my perspective as additional insight."
Home runs in cancer treatment are the goal, but often-times the incremental increases are the treatments that add together to make a difference. The latest data from England show that a Radium injection can provide substantial improvements in patients with far-advanced prostate cancer. I have had patients receive this treatment and have seen successes. This …
Read More “LATE STAGE PROSTATE CANCER TREATMENT IS NICE ADDITION”
Supplementation with Omega 3 fatty acids, the healthy fats that come naturally from fish sources and also are used as supplements like Mega Red, has shown an association with prostate cancer. Journal of the National Cancer Institute report shows a statistical increase in men with high levels of Omega 3’s, having more ‘low grade’ and …
Read More “OMEGA 3 FATTY ACIDS MAY INCREASE RISK FOR PROSTATE CANCER IN MEN”
Zytega is a new medication for prostate cancer that works by blocking testosterone. It is superior to other medications for this purpose and I have personally seen strong results in patients who have used this after failing chemotherapy. Now, a new report on the New England Journal of Medicine, shows that Zytega is effective at …
Read More “ZYTIGA SHOWS MUSCLE IN PROSTATE CANCER TREATMENT”
It is great to have new treatments for patients with advanced cancer, and XTANDI has just been approved for patients with progressive disease who have failed Taxotere (an IV chemotherapy medication). XTANDI (Enzalutamide) is very much like Zytiga…..a previously approved medications for advanced prostate cancer. The medication is a pill that maximally suppressed all testosterone …
Read More “XTANDI….NEW MEDICATION FOR ADVANCED PROSTATE CANCER APPROVED”
A recent study of 6000 men with localized prostate cancer demonstrated a marked reduction in cancer recurrence with the use of aspirin. A 57% reduction in recurrence was noted. This simple measure is worth employing in anyone with a history of prostate cancer, so tell someone you know who has had either surgery or xray …
A recent study of 1000 men with milder forms prostate cancer has questioned the benefits of aggressive treatment (read surgery) in patients with milder stages of disease. The conclusion of the study is that surgical treatment (removal of the prostate) does not prevent cancer deaths in this low risk group. Despite the claims of this …
What with elevated PSA’s that do not show prostate cancer, the increased risk of infection from the prostate biopsies, and the question of ‘overdiagnosis’ of mild disease that does not require treatment…the entire PSA issue has become increasingly unclear. Into that mix, steps the latest study from the NCI (National Cancer Institute). This study of …
Good news for patients treated with hormone deprivation therapy for their prostate cancer…..There is no increase risk in heart disease rate from this treatment. This is an important finding and is documented in a 10-year follow-up study out of Sweden. There has been concern that removing male hormone effects, might have a negative effect on …
A recent study from shows that prostate biopsy, a test done to confirm the diagnosis of prostate cancer and the PSA is elevated, has an increasing risk of serious infection and complications. Since 1996, the risk of significant problems from the procedure has doubled to 7%. This is something I’ve definitely observed over time and …
Read More “MORE CONSIDERATIONS IN PROSTATE CANCER DIAGNOSIS”